Jennifer J. Rhodes - 14 Jul 2021 Form 4/A - Amendment Insider Report for Angion Biomedica Corp. (ELTX)

Role: Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
Signature: /s/ Jennifer J. Rhodes
Issuer symbol: ELTX
Transactions as of: 14 Jul 2021
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 20 Jul 2021, 17:58:57 UTC
Date Of Original Report: 15 Jul 2021
Previous filing: 16 Jun 2021
Next filing: 22 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ELTX	Common Stock						33,020	14 Jul 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 15, 2021, the reporting person erroneously reported a sale of 431 shares of common stock that did not occur. Consequently, this amendment is being filed to correct the original Form 4 to reflect no transaction having occurred.

Remarks:

Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary